(178 days)
Dynamic TiBase abutments are intended for use with dental implants as a support for single-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient.
TRI Screws are intended to secure TRI-matrix® Crown Abutments to TRI-matrix® implants.
Dynamic TiBase abutments are designed for retention of a CAD-CAM fabricated zirconia superstructure where the final two-piece abutment (base and cemented superstructure) is the finished device used for the prosthetic restoration. All subject device bases are made of titanium alloy (Ti-6Al-4V) conforming to ISO 5832-3 and ASTM F136. The Dynamic TiBase abutments are provided in engaging designs for single-unit restorations.
Dynamic TiBase abutments are provided in sizes compatible with the following SGS® Dental Implants System implants:
SGS P1D, Conical connection, 5.0 mm body diameter, 3.5 (3.0 mm) platform; and
SGS P7N, Narrow Conical connection, 3.2 mm body diameter, 2.1 (2.5 mm) platform.
All Dynamic TiBase abutments are provided in a straight design (no angulation in the TiBase portion). All Dynamic TiBase abutments have a prosthetic post with a cut-out to accommodate a restoration with an angled channel for screw access when clinically necessary.
For the compatible SGS P1D Concal connection implant, the Dynamic TiBase abutments are provided with a gingival height (in the titanium base) of 0.5 mm, or 3.0 mm, and a prosthetic platform diameter of 4.3 mm. Angulation and additional gingival height may be provided in the zirconia superstructure. For the compatible SGS P1D Conical connection implant, the abutments have a prosthetic post height (length above the gingival height) of 4.0 mm, and a cut-out height of 2.5 mm.
For the SGS P7N Narrow Conical connection implant, the gingival height (in the titanium base) is 0.5 mm or 1.5 mm. and a prosthetic platform diameter of 3.8 mm. Angulation and additional gingival height may be provided in the zirconia superstructure. For the compatible P7N Narrow Conical connection implant the abutments have a prosthetic post height (length above the gingival height) of 4.5 mm, and a cut-out height of 2.5 mm. Dynamic TiBase abutments with a 4.5 mm maximum post height may be shortened to no less than 4 mm for a single-unit restoration.
The subject device TRI Screws are to be used only to attach TRI-matrix® Crown Abutments. The TRI-matrix® Crown Abutments and TRI-matrix® implants are manufactured by TRI Dental Implants Int. AG and were cleared in K203660. The TRI screws have a hexalobular instrument interface, a screw head diameter of 2.6 mm, 1-72 UNF thread, and an overall length of 5.15 mm or 7.6 mm. The TRI Screws are anodized to a gold color and are only intended to be used with straight abutments. The compatible abutments are made from zirconia and are for direct final restorations.
This is a substantially equivalent (SE) determination letter from the FDA, not a study report. It states that the device is substantially equivalent to legally marketed predicate devices, meaning it has the same intended use and similar technological characteristics. Therefore, it does not contain the detailed information about acceptance criteria and study results you requested for a novel device.
The document states that a non-clinical mechanical testing study was performed to support the performance of the abutments and zirconia superstructure. However, the specific acceptance criteria and detailed results of this study are not provided in this regulatory document.
Here's a breakdown of what can be extracted or inferred based on your request, and what is explicitly not available:
1. A table of acceptance criteria and the reported device performance
- Acceptance Criteria for Substantial Equivalence: The primary acceptance criterion for this FDA clearance is "substantial equivalence" to predicate devices. This means the device has the same intended use and similar technological characteristics (materials, design, manufacturing, sterile processing, etc.), and any differences do not raise new questions of safety or effectiveness.
- Reported Device Performance: The document states that mechanical testing conducted according to ISO 14801 was performed to support the performance of the subject device abutments in conjunction with compatible OEM implants. It also mentions a "non-clinical worst-case MRI review" using scientific rationale and published literature. However, the specific numerical acceptance criteria for these tests (e.g., specific fatigue limits, displacement values) and the actual quantitative results are not provided in this summary. It only states that these tests were performed to mitigate risks.
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- This information is not provided in the document. The mechanical testing would have involved a specific number of samples (e.g., implant-abutment assemblies) tested according to ISO 14801. The document only states that such testing was performed to demonstrate performance. The country of origin for the testing data is not mentioned, but the manufacturer is Talladium España, SL (Spain).
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- This kind of information is not applicable to this type of regulatory submission (Class II dental implant components). There is no "ground truth" established by experts in the context of diagnostic accuracy for this device. The assessment is based on engineering principles, materials science, and mechanical testing against recognized standards.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- This is not applicable as it pertains to expert consensus in diagnostic studies, not mechanical testing of medical devices.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- This is not applicable. This is a physical dental implant component, not an AI diagnostic device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- This is not applicable. This is a physical dental implant component, not an AI diagnostic device.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
- For the mechanical testing, the "ground truth" would be the physical properties and mechanical integrity of the device measured against predetermined performance specifications outlined in relevant ISO standards (e.g., ISO 14801 for fatigue testing of dental implants). For biocompatibility, it's testing against ISO 10993 standards.
8. The sample size for the training set
- This is not applicable. This is not a machine learning or AI device that requires a training set.
9. How the ground truth for the training set was established
- This is not applicable.
Summary of available and missing information regarding acceptance criteria and study:
| Category | Information Provided in Document |
|---|---|
| Acceptance Criteria (General) | Substantial Equivalence to predicate devices (K232151, K182219, K203660) in intended use and technological characteristics. Any differences do not raise new questions of safety or effectiveness. This is the overarching "acceptance criterion" for FDA clearance. |
| Specific Performance Criteria | Mechanical testing conducted according to ISO 14801. Non-clinical worst-case MRI review per FDA guidance (magnetically induced displacement force and torque). Sterility assurance level (SAL) of 10^-6 by overkill method (ANSI/AAMI/ISO 17665-1 and TIR 17665-2). Biocompatibility testing according to ISO 10993-5 (cytotoxicity) for materials ASTM F136 and ISO 13356. Specific numerical acceptance values for these tests are NOT provided. |
| Reported Device Performance | The document states these tests were performed and used to demonstrate substantial equivalence and mitigate risks. Specific numerical results are NOT provided. |
| Study Type(s) | Non-clinical mechanical testing (ISO 14801). Non-clinical MRI safety review. Sterilization validation. Biocompatibility testing. |
| Sample Size (Test Set) | Not provided. |
| Data Provenance (Country, Retrospective/Prospective) | Manufacturer is from Spain (Talladium España, SL). Data provenance details (e.g., where testing was performed, whether data was prospective or retrospective) are not explicitly provided for the non-clinical tests. |
| Number/Qualifications of Experts (Ground Truth) | Not applicable for this type of device. |
| Adjudication Method | Not applicable. |
| MRMC Comparative Effectiveness Study | Not applicable. |
| Standalone Performance Study (AI) | Not applicable. |
| Type of Ground Truth Used | For mechanical testing: adherence to performance specifications in ISO 14801. For biocompatibility: adherence to ISO 10993 standards. For sterilization: achievement of SAL 10^-6 per ANSI/AAMI/ISO 17665. |
| Training Set Size | Not applicable. |
| How Ground Truth for Training Set Established | Not applicable. |
This document is a regulatory communication affirming substantial equivalence based on non-clinical data, not a detailed scientific study report. For the specific acceptance criteria and quantitative performance results, one would typically need to refer to the full 510(k) submission, which is not publicly available in this level of detail.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Talladium España, SL % Kevin Thomas VP & Director of Regulatory Affairs PaxMed International, LLC 12264 El Camino Real Suite 400 San Diego, California 92130
October 21, 2024
Re: K241170
Trade/Device Name: Dynamic TiBase; TRI Screws Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: April 26, 2024 Received: September 17, 2024
Dear Kevin Thomas:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
{2}------------------------------------------------
3
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Andrew I. Steen -S
Andrew I. Steen Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indications for Use
510(k) Number (if known) K241170
Device Name
Dynamic TiBase; TRI Screws
Indications for Use (Describe)
Dynamic TiBase
Dynamic TiBase abutments are intended for use with dental implants as a support for single-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient.
Compatible Implant Systems
| Implant Compatibility | Implant Body Diameter, mm | Implant Platform Diameter, name (mm) |
|---|---|---|
| SGS P1D Conical | 5.0 | 3.5 (3.0 mm) |
| SGS P7N Narrow Conical | 3.2 | 2.1 (2.5 mm) |
All digitally designed custom abutments for use with Dynamic TiBase abutments are to a Talladium validated milling center for manufacture.
TRI Screws
TRI Screws are intended to secure TRI-matrix® Crown Abutments to TRI-matrix® implants.
| Type of Use ( Select one or both, as applicable ) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{4}------------------------------------------------
510(k) Summary K241170 Talladium España, SL Dynamic TiBase; TRI Screws
October 18, 2024
ADMINISTRATIVE INFORMATION
| Manufacturer Name | Talladium España, SLVirginia Woolf, 17Lleida, Lleida, ES 25005Telephone +34 973-289-580 | ||
|---|---|---|---|
| Official Contact | Xavier Soca Filella, General Manager | ||
| Representative/Consultant | Kevin A. Thomas, PhDFloyd G. Larson, MS, MBAPaxMed International, LLC12264 El Camino Real, Suite 400San Diego, CA 92130Telephone +1 858-792-1235Email kthomas@paxmed.comflarson@paxmed.com |
DEVICE NAME AND CLASSIFICATION
| Trade/Proprietary Name | Dynamic TiBase; TRI Screws |
|---|---|
| Common Names | Endosseous dental implant abutment |
| Regulation Number | 21 CFR 872.3630 |
| Regulation Name | Endosseous dental implant abutment |
| Regulatory Class | Class II |
| Product Code | NHA |
| Classification Panel | Dental |
| Reviewing Office | Office of Health Technology 1(Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices) |
| Reviewing Division | Division of Dental and ENT Devices |
PREDICATE DEVICE INFORMATION
Primary Predicate Device K232151, Dynamic TiBase, Talladium España, SL
Reference Devices K182219, SGS® Dental Implants System, SGS International Ltd. K203660, TRI-matrix® Implant Line, TRI Dental Implants Int. AG
{5}------------------------------------------------
INDICATIONS FOR USE STATEMENT
Dynamic TiBase
Dynamic TiBase abutments are intended for use with dental implants as a support for single-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient.
| Implant Compatibility | Implant Body Diameter, mm | Implant Platform Diameter, name (mm) |
|---|---|---|
| SGS P1D Conical | 5.0 | 3.5 (3.0 mm) |
| SGS P7N Narrow Conical | 3.2 | 2.1 (2.5 mm) |
Compatible Implant Systems
All digitally designed custom abutments for use with Dynamic TiBase abutments are to a Talladium validated milling center for manufacture.
TRI Screws
TRI Screws are intended to secure TRI-matrix® Crown Abutments to TRI-matrix® implants.
SUBJECT DEVICE DESCRIPTION
Dynamic TiBase abutments are designed for retention of a CAD-CAM fabricated zirconia superstructure where the final two-piece abutment (base and cemented superstructure) is the finished device used for the prosthetic restoration. All subject device bases are made of titanium alloy (Ti-6Al-4V) conforming to ISO 5832-3 and ASTM F136. The Dynamic TiBase abutments are provided in engaging designs for single-unit restorations.
Dynamic TiBase abutments are provided in sizes compatible with the following SGS® Dental Implants System implants:
SGS P1D, Conical connection, 5.0 mm body diameter, 3.5 (3.0 mm) platform; and
SGS P7N, Narrow Conical connection, 3.2 mm body diameter, 2.1 (2.5 mm) platform.
All Dynamic TiBase abutments are provided in a straight design (no angulation in the TiBase portion). All Dynamic TiBase abutments have a prosthetic post with a cut-out to accommodate a restoration with an angled channel for screw access when clinically necessary.
For the compatible SGS P1D Concal connection implant, the Dynamic TiBase abutments are provided with a gingival height (in the titanium base) of 0.5 mm, or 3.0 mm, and a prosthetic platform diameter of 4.3 mm. Angulation and additional gingival height may be provided in the zirconia superstructure. For the compatible SGS P1D Conical connection implant, the abutments have a prosthetic post height (length above the gingival height) of 4.0 mm, and a cut-out height of 2.5 mm.
For the SGS P7N Narrow Conical connection implant, the gingival height (in the titanium base) is 0.5 mm or 1.5 mm. and a prosthetic platform diameter of 3.8 mm. Angulation and additional gingival height may be provided in the zirconia superstructure. For the compatible P7N Narrow Conical connection implant the abutments have a prosthetic post height (length above the gingival height) of 4.5 mm, and a cut-out height of 2.5 mm. Dynamic TiBase abutments with a 4.5 mm maximum post height may be shortened to no less than 4 mm for a single-unit restoration.
{6}------------------------------------------------
A summary of the subject device Dynamic TiBase compatibilities with the OEM implants is provided in the following Table 1 Summary of the Subject Device Dynamic TiBase Abutments.
| Compatible SGS Dental Implants | Subject DeviceDynamic TiBase Abutments | ||||
|---|---|---|---|---|---|
| Implant | Body Ø | Platform Øname (mm) | Gingival Height | TiBase Ø | Prosthetic Post Height(Maximum height/cut-out height) |
| SGS P1D Conical | 5.0 mm | 3.5 (3.0 mm) | 0.5, 1.5, 3.0 mm | 4.3 mm | 4.0 mm / 2.5 mm |
| SGS P7N Narrow Conical | 3.2 mm | 2.1 (2.5 mm) | 0.5, 1.5 mm | 3.8 mm | 4.5 mm / 2.5 mm |
The compatibility between the subject device abutments and the SGS dental implants has been established on the basis of a contractual agreement and working relationship between SGS International Ltd. and Talladium España, SL to ensure that the subject device abutment screws are designed to fit the corresponding SGS implants.
All zirconia copings (superstructures) for use with the subject device Dynamic TiBase will be made at a Talladium España, SL validated milling center under FDA quality system regulations, and the material will conform to ISO 13356.
The design parameters for the CAD-CAM zirconia superstructure for the Dynamic TiBase vary between the compatible implants. The design parameters for the CAD-CAM zirconia superstructure are summarized in the following Table 2 Summary of the Zirconia Superstructure Design Parameters.
| Compatible SGS Dental Implants | Subject DeviceDynamic TiBase | Zirconia Superstructure | ||||
|---|---|---|---|---|---|---|
| Implant | Body Ø | Platform Ø, name (mm) | Gingival Height, mm | Maximum Angulation | Minimum Wall Thickness | Maximum Gingival Height |
| 0.5 mm | 25° | 0.32 mm | 5.0 mm | |||
| SGS P1DConical | 5.0 mm | 3.5 (3.0 mm) | 1.5 mm | 20° | ||
| 3.0 mm | 15° | |||||
| SGS P7NNarrow Conical | 3.2 mm | 2.1 (2.5 mm) | 0.5 mm | 25° | 0.30 mm | 5.05 mm |
| 1.5 mm | 20° |
Table 2 - Summary of the Zirconia Superstructure Design Parameters
The recommended cement for bonding the zirconia superstructure to the Dynamic TiBases to create the final twopiece abutment is G-CEM LinkAce™, cleared as GAM-200 in K120243.
The subject device TRI Screws are to be used only to attach TRI-matrix® Crown Abutments. The TRI-matrix® Crown Abutments and TRI-matrix® implants are manufactured by TRI Dental Implants Int. AG and were cleared in K203660. The TRI screws have a hexalobular instrument interface, a screw head diameter of 2.6 mm, 1-72 UNF thread, and an overall length of 5.15 mm or 7.6 mm. The TRI Screws are anodized to a gold color and are only intended to be used with straight abutments. The compatible abutments are made from zirconia and are for direct final restorations.
The compatibility between the subject device TRI Screws and the TRI dental implants has been established on the basis of a contractual agreement and working relationship between TRI Dental Implants Int. AG and Talladium España, SL to ensure that the subject device abutment screws are designed to fit the corresponding TRI implants.
{7}------------------------------------------------
PERFORMANCE DATA
Non-clinical data submitted or referenced to demonstrate substantial equivalence included:
- provided in this submission was a non-clinical worst-case MRI review to evaluate the subject device components in the MR environment using scientific rationale and published literature (T.O. Woods, J.G. Delfino, and S. Rajan, "Assessment of Magnetically Induced Displacement Force and Torque on Metal Alloys Used in Medical Devices," Journal of Testing and Evaluation Volume 49, No. 2 (March/April 2021): 783-795), based on the entire system including all variations (all compatible implant bodies, abutments, and fixation screws) and material composition, and the rationale addressed parameters per the FDA guidance document Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment (issued October 2023), including magnetically induced displacement force and torque;
- referenced from K232151 (provided in K212108) was moist heat sterilization for subject devices provided non-● sterile to the end user, validated to a sterility assurance level of 10% by the overkill method according to ANSI/AAMI/ISO 17665-1 and ANSI/AAMI/ISO TIR 17665-2;
- referenced from K232151 (provided in K212108) was biocompatibility testing according to ISO 1093-5 ● (cytotoxicity) for the abutment materials ASTM F136 and ISO 13356;
- provided in this submission was mechanical testing conducted according to ISO 14801 to support the performance ● of the subject device abutments in conjunction with the compatible OEM implants.
No clinical data were included in this submission.
EQUIVALENCE TO MARKETED DEVICES
The subject device abutments and abutment screws are substantially equivalent in intended use to the abutments and abutment screws cleared in the primary predicate device K232151 and to the abutment screws cleared in the reference device K203660. All subject device components are intended for use with endosseous dental implants in the maxilla and mandible to provide functional and esthetic rehabilitation. The Dynamic TiBase portion of the Indications for Use Statement (IFUS) for the subject device is identical to that of the primary predicate device K232151 except for the list of the compatible OEM implants. The TRI Screws portion of the subject device IFUS is nearly identical to the last sentence of the IFUS of the reference device K203660.
All subject device titanium base abutment screws are similar in design, materials, and technological characteristics to the titanium base abutment and abutment screws cleared in the primary predicate device K232151 and to the abutment screws cleared in the reference device K203660. Provided at the end of this attachment are tables comparing the Indications for Use Statements and the technological characteristics of the primary predicate device K232151, and the reference device K203660.
The subject device abutments and abutment screws are manufactured from identical materials, in the identical facilities using the identical manufacturing processes as used for Talladium España, SL abutment screws previously cleared in the primary predicate device titanium base abutments and the titanium base abutments in the primary predicate device K232151 have similar or identical ranges of implantabutment platform diameter, prosthetic platform diameter, and gingival height. The reference device K182219 is for the OEM implant body clearance and substantial equivalence of the implant-abutment platform sizes.
The subject device titanium base abutments are to be used with a zirconia superstructure with similar design parameters as those of the primary predicate K232151. The zirconia material and recommended cement to bond the superstructure to the prosthetic component are the same as those of the primary predicate K232151.
The subject device abutment screws for the compatible SGS® Dental Implants are similar in design, materials, and technological characteristics to the abutment screws cleared in the primary predicate device K232151 (for other OEM implant compatibilities), except for the threads and lengths.
{8}------------------------------------------------
510(k) Summary Page 5 of 7
All subject device components are provided non-sterile and are to be sterilized by the same most heat cycle as in the primary predicate K232151. The subject devices are provided in pouches manufactured from a polyethylene terephthalate (PET) and cast polypropylene (CPP) laminate, identical to the primary predicate K232151.
The subject device titanium base abutments are to be used with a zirconia superstructure to create the final two-piece abutment. The risks associated with the use of an angled zirconia superstructure bonded to the subject device titanium base abutments are mitigated by the mechanical testing according to ISO 14801 provided in this submission.
The subject device abutment screws that are compatible with the TRI-matrix® Implant Line are to be used only with straight abutments. Therefore, mechanical testing for these abutments screws was not required.
Minor differences in the designs, dimensions, sizes, or compatible implant lines among the subject device, the primary predicate device, and the reference devices do not affect substantial equivalence. These minor differences do not impact safety or effectiveness because these differences are related to the compatible implant designs and are mitigated by the mechanical performance testing.
CONCLUSION
The subject device, the primary predicate device, and the reference devices have the same intended use, have similar technological characteristics, and are made of identical or similar materials. The subject device and the primary predicate device encompass the same range of physical dimensions, are packaged in similar materials, and are sterilized using similar methods.
The data included in this submission demonstrate substantial equivalence to the predicate device listed above.
The basis for the belief of Talladium España, SL that the substantially equivalent to the predicate device and the reference devices is summarized in the following tables Substantial Equivalence - Indications for Use Statements and Substantial Equivalence - Technological Characteristics.
{9}------------------------------------------------
Substantial Equivalence – Indications for Use Statements
| Subject DeviceK241170Dynamic TiBaseTalladium España, SL | Indications for Use Statements | |
|---|---|---|
| Dynamic TiBaseDynamic TiBase abutments are intended for use with dental implants as a support for single-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient. | ||
| Compatible Implant Systems | ||
| Implant Compatibility | Implant Body Diameter, mmImplant Platform Diameter, name (mm) | |
| SGS P1D Conical | 5.03.5 (3.0 mm) | |
| SGS P7N Narrow Conical | 3.22.1 (2.5 mm) | |
| All digitally designed custom abutments for use with Dynamic TiBase abutments are to be sent to a Talladium validated milling center for manufacture.TRI ScrewsTRI Screws are intended to secure TRI-matrix® Crown Abutments to TRI-matrix® implants. | ||
| Primary Predicate DeviceK232151Dynamic TiBaseTalladium España, SL | Dynamic TiBase abutments are intended for use with dental implants as a support for single-unit or multi-unit prostheses in the maxillary or mandibular arch of a partially or fully edentulous patient. | |
| Compatible Implant Systems | ||
| Implant Compatibility | Implant Body Diameter, mmImplant Platform, mm | |
| Astra Tech OsseoSpeed TX | 3.5, 4.03.5/4.0 | |
| 4.5, 5.04.5/5.0 | ||
| Biomet 3i OSSEOTITE®Certain® | 4.03.4 | |
| 4.0, 5.04.1 | ||
| MegaGen AnyRidge | 4.0, 4.4, 4.9, 5.43.5 | |
| 3.53.5 (NP) | ||
| Nobel Biocare NobelActive® | 4.3, 5.03.9 (RP) | |
| 5.55.1 (WP) | ||
| 3.7, 4.13.5 | ||
| Zimmer Tapered Screw-Vent® | 4.74.5 | |
| 6.05.7 | ||
| All digitally designed custom abutments for use with Dynamic TiBase abutments are to be sent to a Talladium validated milling center for manufacture. | ||
| Reference DeviceK203660TRI-matrix® Implant LineTRI Dental Implants Int. AG | The TRI-matrix® Implant Line is intended for placement in the bone of the maxillary or mandibular arch for the rehabilitation of edentulous and partially edentulous patients. TRI-matrix® Implant Line allows for one and two stage surgical procedures. When a one-stage surgical procedure is applied, the implant may be immediately loaded when good primary stability is achieved and with appropriate occlusal loading. TRI-matrix® Implant Line 6.5 mm implants are intended for delayed loading only.The TRI-matrix® Crown Abutment is intended for use with an endosseous implant to function as a substructure that also serves as the final restoration, in a partially or completely edentulous patient. The abutment screw is intended to secure the TRI-matrix® Crown Abutment to the endosseous implant. |
{10}------------------------------------------------
| Comparison | Subject Device | Predicate Device |
|---|---|---|
| K241170Dynamic TiBaseTalladium España, SL | K232151Dynamic TiBaseTalladium España, SL | |
| Reason for Predicate Device | Not applicable | IFUS; abutment designs; materials;manufacturing; biocompatibility;sterilization |
| Product Codes | NHA | NHA |
| Intended Use | Functional and esthetic rehabilitation of theedentulous mandible or maxilla | Functional and esthetic rehabilitation of theedentulous mandible or maxilla |
| Abutment Designs | ||
| Abutment Types | CAD-CAM titanium base abutments | CAD-CAM titanium base abutments |
| Prosthesis Attachment | Cement-retained, screw-retained | Cement-retained, screw-retained |
| Restoration | Single-unit | Single-unit and multi-unit |
| Prosthetic Interface Connections | Internal | Internal |
| Implant-Abutment Platform Diameter | 2.5 mm - 3.0 mm | 3.4 mm - 5.7 mm |
| Prosthetic Platform Diameter | 3.8 mm - 4.3 mm | 4.3 mm - 5.9 mm |
| Gingival Height (in the TiBase) | 0.5 mm - 3 mm | 0.3 mm - 5 mm |
| Abutment Angulation, degrees (in theTiBase) | Straight (0°) | Straight (0°) |
| Zirconia Superstructure DesignParameters | ||
| Minimum wall thickness | 0.30 mm | 0.32 mm |
| Minimum post height (length abovethe gingival height)for single-unit restorations | 4.0 mm | 4.0 mm |
| Minimum gingival height (GH) of thesuperstructure | 0 mm; all bases have minimum GH 0.5 mm | 0 mm; all bases have minimum GH 0.3 mm |
| Maximum gingival height (of thesuperstructure) | 5.05 mm | 5.18 mm |
| Angulation of Finished Abutment | Up to 25° | Up to 30° |
| Cement to bond zirconiasuperstructure to the abutment base | G-CEM LinkAce™(cleared as GAM-200 in K120243) | G-CEM LinkAce™(cleared as GAM-200 in K120243) |
| Abutment Base Material | Titanium alloy, ASTM F136, ISO 5832-3 | Titanium alloy, ASTM F136, ISO 5832-3 |
| Abutment Screw Material | Titanium alloy, ASTM F136, ISO 5832-3 | Titanium alloy, ASTM F136, ISO 5832-3 |
| Abutment Screw Instrument Interface | Hexalobular | Hexalobular |
| Superstructure Material | Zirconia, ISO 13356 | Zirconia, ISO 13356 |
| How Provided | ||
| Sterilization | Provided non-sterile;to be moist heat sterilized by the end user | Provided non-sterile;to be moist heat sterilized by the end user |
| Usage - All Components | Single patient, single use | Single patient, single use |
Substantial Equivalence – Technological Characteristics
§ 872.3630 Endosseous dental implant abutment.
(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)